control group:TCM placebo
Sponsors
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Conditions
idiopathic pulmonary fibrosis
Early Phase 1
Study on the Biomarker Screening of Idiopathic Pulmonary Fibrosis Based on Metabonomics and the Effect of TCM Treatment Based on Syndrome Differentiation
RecruitingITMCTR2000003588
Start: 2020-04-24Updated: 2023-02-20
Study on the Biomarker Screening of Idiopathic Pulmonary Fibrosis Based on Metabonomics and the Effect of TCM Treatment Based on Syndrome Differentiation
RecruitingChiCTR2000035807
Start: 2020-04-24Updated: 2020-08-24